West Pharmaceutical Services Inc (NYSE:WST)
| 351.79 Delayed Data As of Dec 01 |  +1.03 / +0.29%Today’s Change | 224.15 Today|||52-Week Range 415.73 | +49.48% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 1.4B | 1.5B | 1.6B | 1.7B | |
| Cost of Goods Sold | 854.0M | 917.4M | 988.3M | 1.1B | ||
| Depreciation And Amortization | 89.9M | 90.7M | 96.7M | 104.4M | ||
| Operating Expenses | Gross Income | 454.1M | 501.0M | 515.4M | 546.5M | |
| General Expenses | 267.1M | 276.6M | 281.7M | 303.2M | ||
| Other Operating Expenses | 0.00 | 8.9M | 0.00 | 0.00 | ||
| Research And Development | 34.1M | 36.8M | 39.1M | 40.3M | ||
| Total Operating Expenses | 1.2B | 1.3B | 1.4B | 1.5B | ||
| Non-Operating Expenses | Operating Income | 187.0M | 215.5M | 233.7M | 243.3M | |
| Extraordinary Credit | 0.00 | 2.2M | 2.4M | 2.7M | ||
| Extraordinary Charge | -62.5M | -2.3M | -11.4M | -9.1M | ||
| Interest Expense On Debt | 13.2M | 10.0M | 9.4M | 8.9M | ||
| Equity In Earnings | 5.8M | 8.2M | 9.2M | 7.6M | ||
| Other Expenses | 1.7M | -20.3M | 3.1M | 9.7M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 116.1M | 189.8M | 222.4M | 240.7M | |
| Income Taxes | -26.3M | -54.4M | -80.9M | -41.4M | ||
| Net Income | 95.6M | 143.6M | 150.7M | 206.9M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 72.0M | 73.3M | 73.9M | 73.9M | |
| Shares To Calculate EPS Diluted | 73.8M | 75.0M | 75.8M | 75.4M | ||
| Earnings Per Share | EPS | $1.30 | $1.91 | $1.99 | $2.74 | |
| EPS Diluted | $1.30 | $1.91 | $1.99 | $2.74 | ||
